NAMUH, Ginkgo Bioworks Ink Partnership To Develop Functional Oligosaccharides

RTTNews | 979 days ago
NAMUH, Ginkgo Bioworks Ink Partnership To Develop Functional Oligosaccharides

(RTTNews) - Infant nutrition company NAMUH and Ginkgo Bioworks Holdings, Inc. (DNA) announced Wednesday a multi-product collaboration to develop functional oligosaccharides that are structurally identical to those found in human breast milk.

NAMUH's mission is to create complete infant formula products substantially comparable to human breast milk, down to the molecular level.

Human Milk Oligosaccharides (HMOs) are essential fiber-like nutrients unique to human milk that provide an important energy source to beneficial gut bacteria in infants.

Despite being the third most abundant component in human milk, HMOs are currently a small component in infant formulas, if present at all.

Currently, NAMUH's proprietary technology provides for a cost-effective source of a family of HMOs via yeast fermentation.

Through this partnership, NAMUH will leverage Ginkgo's expertise in yeast strain engineering and fermentation process development to enable the production of various HMOs through yeast fermentation and work to unlock the possibility of making infant formula nutritionally robust and much closer to human breast milk.

read more
Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced Thursday the acquisition of microbial innovation firm AgBiome, Inc.'s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline.
RTTNews | 530 days ago
Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

Ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference later on Wednesday, Ginkgo Bioworks (DNA) said it expects to meet its previously disclosed new program and revenue guidance ranges in 2023, based on its preliminary unaudited estimates.
RTTNews | 621 days ago
Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Cell programming firm Ginkgo Bioworks Holdings, Inc. (DNA) and biotechnology company Zymergen, Inc. (ZY) announced Monday they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization.
RTTNews | 1156 days ago
European Shares Seen Flat To Higher At Open

European Shares Seen Flat To Higher At Open

European stocks are seen opening broadly higher on Tuesday, even as the upside may remain capped amid ongoing volatility in the bond markets due to political uncertainty in France and Germany's plans to ramp up debt issuance.
RTTNews | 2h 9min ago
European Economic News Preview: Eurozone Flash PMI Data Due

European Economic News Preview: Eurozone Flash PMI Data Due

Flash composite purchasing managers' survey results from the euro area and the UK are the top economic news due on Tuesday. At 3.15 am ET, France's flash composite PMI survey results are due. The composite output index is forecast to edge up to 49.9 in September from 49.8 in the previous month.
RTTNews | 2h 24min ago